Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.
CONCLUSION: PR but not EZ treatment reduced duodenal cholesterol transporter expression in mice. PR-induced increases in LXRa mRNA levels may be involved in attenuation of NPC1L1 expression, subsequently decreasing intestinal cholesterol absorption. This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.
PMID: 26670369 [PubMed - as supplied by publisher]
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Kawase A, Hata S, Takagi M, Iwaki M Tags: J Pharm Pharm Sci Source Type: research
More News: Cholesterol | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver | Liver Cancer | Niemann-Pick Disease | Pravastatin | Statin Therapy | Urology & Nephrology | Vytorin | Zetia